Skip to main content
Erschienen in: Acta Neuropathologica 2/2012

01.08.2012 | Original Paper

Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis

verfasst von: Graham R. Campbell, Yevgenya Kraytsberg, Kim J. Krishnan, Nobuhiko Ohno, Iryna Ziabreva, Amy Reeve, Bruce D. Trapp, Jia Newcombe, Richard Reynolds, Hans Lassmann, Konstantin Khrapko, Doug M. Turnbull, Don J. Mahad

Erschienen in: Acta Neuropathologica | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

Mitochondrial DNA deletions (∆-mtDNA) have been implicated in the pathogenesis of Alzheimer’s disease (AD), multiple sclerosis (MS) and Parkinson’s disease (PD), as well as ageing. Clonal expansion of ∆-mtDNA is the process by which a mutant mtDNA molecule increases to high levels within a single cell containing both wild-type and mutant mtDNA. Unlike in AD and PD, the diffuse inflammatory process in MS involves the choroid plexus, and mitochondria are exposed to reactive oxygen and nitrogen species over a prolonged period. We determined the extent of respiratory enzyme deficiency and ∆-mtDNA at a single cell level within choroid plexus epithelial cells in MS as well as in AD, PD and controls. The respiratory enzyme-deficient (lacking complex IV and with intact complex II activity) cells were more prevalent within the choroid plexus in AD, MS and PD compared with controls. The main catalytic subunit of complex IV (subunit-I of cytochrome c oxidase) was lacking in significantly more respiratory enzyme-deficient cells in MS compared with AD, PD and controls. The single cell analysis showed a fourfold increase in the percentage of respiratory enzyme-deficient choroid plexus epithelial cells harbouring clonally expanded ∆-mtDNA in MS. Our findings establish clonal expansion of ∆-mtDNA as a feature relatively more prominent within the choroid plexus epithelium in MS than AD, PD or controls. We propose clonal expansion of ∆-mtDNA as a molecular link between inflammation and part of a delayed cellular energy failure in MS.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bender A, Schwarzkopf RM, McMillan A et al (2008) Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions. J Neurol 255:1231–1235PubMedCrossRef Bender A, Schwarzkopf RM, McMillan A et al (2008) Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions. J Neurol 255:1231–1235PubMedCrossRef
2.
Zurück zum Zitat Bender A, Krishnan KJ, Morris CM et al (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38:515–517PubMedCrossRef Bender A, Krishnan KJ, Morris CM et al (2006) High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet 38:515–517PubMedCrossRef
3.
Zurück zum Zitat Betts J, Lightowlers RN, Turnbull DM (2004) Neuropathological aspects of mitochondrial DNA disease. Neurochem Res 29:505–511PubMedCrossRef Betts J, Lightowlers RN, Turnbull DM (2004) Neuropathological aspects of mitochondrial DNA disease. Neurochem Res 29:505–511PubMedCrossRef
4.
Zurück zum Zitat Broadwater L, Pandit A, Clements R et al (2011) Analysis of the mitochondrial proteome in multiple sclerosis cortex. Biochim Biophys Acta 1812:630–641PubMedCrossRef Broadwater L, Pandit A, Clements R et al (2011) Analysis of the mitochondrial proteome in multiple sclerosis cortex. Biochim Biophys Acta 1812:630–641PubMedCrossRef
5.
Zurück zum Zitat Burney S, Caulfield JL, Niles JC, Wishnok JS, Tannenbaum SR (1999) The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat Res 424:37–49PubMedCrossRef Burney S, Caulfield JL, Niles JC, Wishnok JS, Tannenbaum SR (1999) The chemistry of DNA damage from nitric oxide and peroxynitrite. Mutat Res 424:37–49PubMedCrossRef
6.
Zurück zum Zitat Campbell GR, Ziabreva I, Reeve AK et al (2011) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 69:481–492PubMedCrossRef Campbell GR, Ziabreva I, Reeve AK et al (2011) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 69:481–492PubMedCrossRef
7.
Zurück zum Zitat Cornford EM, Varesi JB, Hyman S, Damian RT, Raleigh MJ (1997) Mitochondrial content of choroid plexus epithelium. Exp Brain Res 116:399–405PubMedCrossRef Cornford EM, Varesi JB, Hyman S, Damian RT, Raleigh MJ (1997) Mitochondrial content of choroid plexus epithelium. Exp Brain Res 116:399–405PubMedCrossRef
8.
Zurück zum Zitat Cottrell DA, Ince PG, Wardell TM, Turnbull DM, Johnson MA (2001) Accelerated ageing changes in the choroid plexus of a case with multiple mitochondrial DNA deletions. Neuropathol Appl Neurobiol 27:206–214PubMedCrossRef Cottrell DA, Ince PG, Wardell TM, Turnbull DM, Johnson MA (2001) Accelerated ageing changes in the choroid plexus of a case with multiple mitochondrial DNA deletions. Neuropathol Appl Neurobiol 27:206–214PubMedCrossRef
9.
Zurück zum Zitat Cottrell DA, Blakely EL, Johnson MA, Ince PG, Turnbull DM (2001) Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD. Neurology 57:260–264PubMedCrossRef Cottrell DA, Blakely EL, Johnson MA, Ince PG, Turnbull DM (2001) Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD. Neurology 57:260–264PubMedCrossRef
10.
Zurück zum Zitat Cottrell DA, Blakely EL, Johnson MA, Ince PG, Borthwick GM, Turnbull DM (2001) Cytochrome c oxidase deficient cells accumulate in the hippocampus and choroid plexus with age. Neurobiol Aging 22:265–272PubMedCrossRef Cottrell DA, Blakely EL, Johnson MA, Ince PG, Borthwick GM, Turnbull DM (2001) Cytochrome c oxidase deficient cells accumulate in the hippocampus and choroid plexus with age. Neurobiol Aging 22:265–272PubMedCrossRef
11.
Zurück zum Zitat Coulter-Mackie MB, Applegarth DA, Toone JR, Gagnier L (1998) A protocol for detection of mitochondrial DNA deletions: characterization of a novel deletion. Clin Biochem 31:627–632PubMedCrossRef Coulter-Mackie MB, Applegarth DA, Toone JR, Gagnier L (1998) A protocol for detection of mitochondrial DNA deletions: characterization of a novel deletion. Clin Biochem 31:627–632PubMedCrossRef
12.
Zurück zum Zitat Dutta R, McDonough J, Yin X et al (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59:478–489PubMedCrossRef Dutta R, McDonough J, Yin X et al (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59:478–489PubMedCrossRef
13.
Zurück zum Zitat Elson JL, Samuels DC, Turnbull DM, Chinnery PF (2001) Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age. Am J Hum Genet 68:802–806PubMedCrossRef Elson JL, Samuels DC, Turnbull DM, Chinnery PF (2001) Random intracellular drift explains the clonal expansion of mitochondrial DNA mutations with age. Am J Hum Genet 68:802–806PubMedCrossRef
14.
Zurück zum Zitat Engelhardt B, Sorokin L (2009) The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol 31:497–511PubMedCrossRef Engelhardt B, Sorokin L (2009) The blood–brain and the blood–cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol 31:497–511PubMedCrossRef
15.
Zurück zum Zitat Engelhardt B, Wolburg-Buchholz K, Wolburg H (2001) Involvement of the choroid plexus in central nervous system inflammation. Microsc Res Tech 52:112–129PubMedCrossRef Engelhardt B, Wolburg-Buchholz K, Wolburg H (2001) Involvement of the choroid plexus in central nervous system inflammation. Microsc Res Tech 52:112–129PubMedCrossRef
16.
Zurück zum Zitat Fischer MT, Sharma R, Lim JL et al (2012) NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 135:886–899PubMedCrossRef Fischer MT, Sharma R, Lim JL et al (2012) NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain 135:886–899PubMedCrossRef
17.
Zurück zum Zitat Fukui H, Moraes CT (2009) Mechanisms of formation and accumulation of mitochondrial DNA deletions in aging neurons. Hum Mol Genet 18:1028–1036PubMedCrossRef Fukui H, Moraes CT (2009) Mechanisms of formation and accumulation of mitochondrial DNA deletions in aging neurons. Hum Mol Genet 18:1028–1036PubMedCrossRef
18.
Zurück zum Zitat Haider L, Fischer MT, Frischer JM et al (2011) Oxidative damage in multiple sclerosis lesions. Brain 134:1914–1924PubMedCrossRef Haider L, Fischer MT, Frischer JM et al (2011) Oxidative damage in multiple sclerosis lesions. Brain 134:1914–1924PubMedCrossRef
19.
Zurück zum Zitat Han W, Chen S, Yu KN, Wu L (2010) Nitric oxide mediated DNA double strand breaks induced in proliferating bystander cells after alpha-particle irradiation. Mutat Res 684:81–89PubMedCrossRef Han W, Chen S, Yu KN, Wu L (2010) Nitric oxide mediated DNA double strand breaks induced in proliferating bystander cells after alpha-particle irradiation. Mutat Res 684:81–89PubMedCrossRef
20.
Zurück zum Zitat Hauser SL, Oksenberg JR (2006) The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52:61–76PubMedCrossRef Hauser SL, Oksenberg JR (2006) The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 52:61–76PubMedCrossRef
21.
Zurück zum Zitat Kiryu-Seo S, Ohno N, Kidd GJ, Komuro H, Trapp BD (2010) Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport. J Neurosci 30:6658–6666PubMedCrossRef Kiryu-Seo S, Ohno N, Kidd GJ, Komuro H, Trapp BD (2010) Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport. J Neurosci 30:6658–6666PubMedCrossRef
22.
Zurück zum Zitat Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K (2006) Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 38:518–520PubMedCrossRef Kraytsberg Y, Kudryavtseva E, McKee AC, Geula C, Kowall NW, Khrapko K (2006) Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 38:518–520PubMedCrossRef
23.
Zurück zum Zitat Krishnan KJ, Ratnaike TE, Gruyter HL, Jaros E, Turnbull DM. (2011) Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer’s disease. Neurobiol Aging [Epub ahead of print] Krishnan KJ, Ratnaike TE, Gruyter HL, Jaros E, Turnbull DM. (2011) Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer’s disease. Neurobiol Aging [Epub ahead of print]
24.
Zurück zum Zitat Krishnan KJ, Reeve AK, Samuels DC et al (2008) What causes mitochondrial DNA deletions in human cells? Nat Genet 40:275–279PubMedCrossRef Krishnan KJ, Reeve AK, Samuels DC et al (2008) What causes mitochondrial DNA deletions in human cells? Nat Genet 40:275–279PubMedCrossRef
25.
Zurück zum Zitat Larsson NG (2010) Somatic mitochondrial DNA mutations in mammalian aging. Annu Rev Biochem 79:683–706PubMedCrossRef Larsson NG (2010) Somatic mitochondrial DNA mutations in mammalian aging. Annu Rev Biochem 79:683–706PubMedCrossRef
26.
Zurück zum Zitat Mahad DJ, Ziabreva I, Campbell G et al (2009) Mitochondrial changes within axons in multiple sclerosis. Brain 132:1161–1174PubMedCrossRef Mahad DJ, Ziabreva I, Campbell G et al (2009) Mitochondrial changes within axons in multiple sclerosis. Brain 132:1161–1174PubMedCrossRef
27.
Zurück zum Zitat Mahad DJ, Ziabreva I, Campbell G et al (2009) Detection of cytochrome c oxidase activity and mitochondrial proteins in single cells. J Neurosci Methods 184:310–319PubMedCrossRef Mahad DJ, Ziabreva I, Campbell G et al (2009) Detection of cytochrome c oxidase activity and mitochondrial proteins in single cells. J Neurosci Methods 184:310–319PubMedCrossRef
28.
Zurück zum Zitat Nicholas A, Kraytsberg Y, Guo X, Khrapko K (2009) On the timing and the extent of clonal expansion of mtDNA deletions: evidence from single-molecule PCR. Exp Neurol 218:316–319PubMedCrossRef Nicholas A, Kraytsberg Y, Guo X, Khrapko K (2009) On the timing and the extent of clonal expansion of mtDNA deletions: evidence from single-molecule PCR. Exp Neurol 218:316–319PubMedCrossRef
29.
Zurück zum Zitat Nijst TQ, Wevers RA, Schoonderwaldt HC, Hommes OR, de Haan AF (1990) Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia. J Neurol Neurosurg Psychiatry 53:951–954PubMedCrossRef Nijst TQ, Wevers RA, Schoonderwaldt HC, Hommes OR, de Haan AF (1990) Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia. J Neurol Neurosurg Psychiatry 53:951–954PubMedCrossRef
30.
Zurück zum Zitat Nisoli E, Clementi E, Paolucci C et al (2003) Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299:896–899PubMedCrossRef Nisoli E, Clementi E, Paolucci C et al (2003) Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299:896–899PubMedCrossRef
31.
Zurück zum Zitat Old SL, Johnson MA (1989) Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle. Histochem J 21:545–555PubMedCrossRef Old SL, Johnson MA (1989) Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle. Histochem J 21:545–555PubMedCrossRef
32.
Zurück zum Zitat Onyango I, Khan S, Miller B, Swerdlow R, Trimmer P, Bennett P Jr (2006) Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer’s disease. J Alzheimers Dis 9:183–193PubMed Onyango I, Khan S, Miller B, Swerdlow R, Trimmer P, Bennett P Jr (2006) Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer’s disease. J Alzheimers Dis 9:183–193PubMed
33.
Zurück zum Zitat Perez-Gracia E, Blanco R, Carmona M, Carro E, Ferrer I (2009) Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer’s disease. Acta Neuropathol 118:497–504PubMedCrossRef Perez-Gracia E, Blanco R, Carmona M, Carro E, Ferrer I (2009) Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer’s disease. Acta Neuropathol 118:497–504PubMedCrossRef
34.
Zurück zum Zitat Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J (2006) Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis. J Biol Chem 281:31950–31962PubMedCrossRef Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J (2006) Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis. J Biol Chem 281:31950–31962PubMedCrossRef
35.
36.
Zurück zum Zitat Ross JM (2011) Visualization of mitochondrial respiratory function using cytochrome c oxidase/succinate dehydrogenase (COX/SDH) double-labeling histochemistry. J Vis Exp 57:e3266 Ross JM (2011) Visualization of mitochondrial respiratory function using cytochrome c oxidase/succinate dehydrogenase (COX/SDH) double-labeling histochemistry. J Vis Exp 57:e3266
37.
Zurück zum Zitat Schapira AH, Jenner P (2011) Etiology and pathogenesis of Parkinson’s disease. Mov Disord 26:1049–1055PubMedCrossRef Schapira AH, Jenner P (2011) Etiology and pathogenesis of Parkinson’s disease. Mov Disord 26:1049–1055PubMedCrossRef
38.
Zurück zum Zitat Serrano M, Garcia-Silva MT, Martin-Hernandez E et al (2010) Kearns-Sayre syndrome: cerebral folate deficiency, MRI findings and new cerebrospinal fluid biochemical features. Mitochondrion 10:429–432PubMedCrossRef Serrano M, Garcia-Silva MT, Martin-Hernandez E et al (2010) Kearns-Sayre syndrome: cerebral folate deficiency, MRI findings and new cerebrospinal fluid biochemical features. Mitochondrion 10:429–432PubMedCrossRef
39.
Zurück zum Zitat Spector R, Johanson CE (2010) Choroid plexus failure in the Kearns-Sayre syndrome. Cerebrospinal Fluid Res 7:14PubMedCrossRef Spector R, Johanson CE (2010) Choroid plexus failure in the Kearns-Sayre syndrome. Cerebrospinal Fluid Res 7:14PubMedCrossRef
40.
Zurück zum Zitat Strazielle N, Ghersi-Egea JF (2000) Choroid plexus in the central nervous system: biology and physiopathology. J Neuropathol Exp Neurol 59:561–574PubMed Strazielle N, Ghersi-Egea JF (2000) Choroid plexus in the central nervous system: biology and physiopathology. J Neuropathol Exp Neurol 59:561–574PubMed
41.
Zurück zum Zitat Tanji K, Schon EA, DiMauro S, Bonilla E (2000) Kearns-Sayre syndrome: oncocytic transformation of choroid plexus epithelium. J Neurol Sci 178:29–36PubMedCrossRef Tanji K, Schon EA, DiMauro S, Bonilla E (2000) Kearns-Sayre syndrome: oncocytic transformation of choroid plexus epithelium. J Neurol Sci 178:29–36PubMedCrossRef
42.
Zurück zum Zitat Tondo M, Malaga I, O’Callaghan M et al (2011) Biochemical parameters to assess choroid plexus dysfunction in Kearns-Sayre syndrome patients. Mitochondrion 11:867–870PubMedCrossRef Tondo M, Malaga I, O’Callaghan M et al (2011) Biochemical parameters to assess choroid plexus dysfunction in Kearns-Sayre syndrome patients. Mitochondrion 11:867–870PubMedCrossRef
43.
Zurück zum Zitat Vercellino M, Votta B, Condello C et al (2008) Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological study. J Neuroimmunol 199:133–141PubMedCrossRef Vercellino M, Votta B, Condello C et al (2008) Involvement of the choroid plexus in multiple sclerosis autoimmune inflammation: a neuropathological study. J Neuroimmunol 199:133–141PubMedCrossRef
44.
Zurück zum Zitat Witte ME, Geurts JJ, de Vries HE, van der Valk P, van Horssen J (2010) Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion 10:411–418PubMedCrossRef Witte ME, Geurts JJ, de Vries HE, van der Valk P, van Horssen J (2010) Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration? Mitochondrion 10:411–418PubMedCrossRef
45.
Zurück zum Zitat Witte ME, Bo L, Rodenburg RJ et al (2009) Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol 219:193–204PubMedCrossRef Witte ME, Bo L, Rodenburg RJ et al (2009) Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol 219:193–204PubMedCrossRef
46.
Zurück zum Zitat Wolburg H, Paulus W (2010) Choroid plexus: biology and pathology. Acta Neuropathol 119:75–88PubMedCrossRef Wolburg H, Paulus W (2010) Choroid plexus: biology and pathology. Acta Neuropathol 119:75–88PubMedCrossRef
47.
Zurück zum Zitat Zambonin JL, Zhao C, Ohno N et al (2011) Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis. Brain 134:1901–1913PubMedCrossRef Zambonin JL, Zhao C, Ohno N et al (2011) Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis. Brain 134:1901–1913PubMedCrossRef
Metadaten
Titel
Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis
verfasst von
Graham R. Campbell
Yevgenya Kraytsberg
Kim J. Krishnan
Nobuhiko Ohno
Iryna Ziabreva
Amy Reeve
Bruce D. Trapp
Jia Newcombe
Richard Reynolds
Hans Lassmann
Konstantin Khrapko
Doug M. Turnbull
Don J. Mahad
Publikationsdatum
01.08.2012
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 2/2012
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-012-1001-9

Weitere Artikel der Ausgabe 2/2012

Acta Neuropathologica 2/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.